The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Nabriva Therapeutics plc(NASDAQ:NBRV) 
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneu...
Nabriva Therapeutics plc Days Payable Outstanding ttm (DPO)
Nabriva Therapeutics plc Days Receivable Outstanding ttm (DSO)
Nabriva Therapeutics plc Days Inventory Outstanding ttm (DIO)
Nabriva Therapeutics plc Op Cashflow Per Share ttm
Nabriva Therapeutics plc Free Cashflow Per Share ttm
Nabriva Therapeutics plc Cash Per Share ttm
Nabriva Therapeutics plc P/S ratio ttm
Nabriva Therapeutics plc (GAAP) P/E ratio ttm
Nabriva Therapeutics plc P/B ratio ttm
No extra charts and metrics for this ticker.